Pfizer Corporation

Ziarco Pharma Ltd.

Michael Yeadon

Wai Leung Liu

Lynn Purkins

The present invention relates to a pharmaceutical composition for topical administration comprising a compound of formula I, 3-{4-[2-{5-chloro-1-(diphenylmethyl)-2-[2-({[2-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethyl]sulfonyl}phenyl}propanoic acid: or pharmaceutically acceptable salts thereof; and to methods of treating inflammation comprising topical administration of a compositions comprising a compound of formula I.

Pharmaceutical composition for topical administration

The present invention relates to a combination comprising (a) an adenosine Areceptor agonist as define herein and (b) an adrenergic &#x3b2;2 receptor agonist, for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.

Pharmaceutical combination

The present invention relates to a combination comprising (a) an adenosine Areceptor agonist as defined herein and (b) an adrenergic &#x3b2;2 receptor agonist, for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.

Growing community of inventors

Sandwich, United Kingdom

Michael Yeadon